Erratum to Tetramer-visualized gluten-specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge by Christophersen et al., (United European Gastroenterology Journal (2014), 2, 268-278, 10.1177/2050640614540154);Tetramer-visualized gluten-specific CD4+ t cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge

United European Gastroenterology Journal

Volumn 2, Issue 4, 2014, Pages 268-

  Christophersen, Asbjørn ^a   Ráki, Melinda ^a   Bergseng, Elin ^a   Lundin, Knut Ea ^a   Jahnsen, Jørgen ^b   Sollid, Ludvig M ^a   Qiao, Shuo Wang ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Blood test; Celiac disease; Diagnostic marker; Diagnostics; Gliadin; Gluten; Gluten reactivity; Histology; Human leukocyte antigen; Immunology; T cells

Indexed keywords

TETRAMER;

ADULT; ARTICLE; CELIAC DISEASE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GLUTEN FREE DIET; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STIMULATION;

EID: 84908121195     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640614553383     Document Type: Erratum

References (35)

1. Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut 2012; 62: 43-52.
2. Wieser H. Chemistry of gluten proteins. Food Microbiol 2007; 24: 115-119.
3. Green PH and Cellier C. Celiac disease. N Engl J Med 2007; 357: 1731-1743.
4. Husby S, Koletzko S, Korponay-Szabo IR, et al. European Society for Pediatric Gastroenterology, Hepatology and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54: 136-160.
5. American Gastroenterological Association (AGA). Institute medical position statement on the diagnosis and management of celiac disease. Gastroenterology 2006; 131: 1977-1980.
6. Dickey W, Hughes DF and McMillan SA. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth. Scand J Gastroenterol 2000; 35: 181-183.
7. Kurppa K, Collin P, Viljamaa M, et al. Diagnosing mild enteropathy celiac disease: A randomized, controlled clinical study. Gastroenterology 2009; 136: 816-823.
8. Sollid LM. Coeliac disease: Dissecting a complex inflammatory disorder. Nat Rev Immunol 2002; 2: 647-655.
9. Lundin KE, Scott H, Hansen T, et al. Gliadin-specific, HLA-DQ (alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993; 178: 187-196.
10. Molberg Ø, Kett K, Scott H, et al. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol 1997; 46: 103-109.
11. Shan L, Molberg O, Parrot I, et al. Structural basis for gluten intolerance in celiac sprue. Science 2002; 297: 2275-2279.
12. Lundin KE, Scott H, Fausa O, et al. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin, when presented by DQ8. Hum Immunol 1994; 41: 285-291.
13. Anderson RP, Degano P, Godkin AJ, et al. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000; 6: 337-342.
14. Raki M, Fallang LE, Brottveit M, et al. Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients. Proc Natl Acad Sci USA 2007; 104: 2831-2836.
15. Pepper M and Jenkins MK. Origins of CD4(þ) effector and central memory T cells. Nat Immunol 2011; 12: 467-471.
16. Quarsten H, McAdam SN, Jensen T, et al. Staining of celiac disease-relevant T cells by peptide-DQ2 multimers. J Immunol 2001; 167: 4861-4868.
17. Moon JJ, Chu HH, Pepper M, et al. Naive CD4(þ) T-cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 2007; 27: 203-213.
18. Sallusto F, Lenig D, Forster R, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-712.
19. Molberg Ø, McAdam SN, Lundin KE, et al. Studies of gliadin-specific T cells in celiac disease. Methods Mol Med 2000; 41: 105-124.
20. Kwok WW, Tan V, Gillette L, et al. Frequency of epitope-specific naive CD4þ T cells correlates with immunodominance in the human memory repertoire. J Immunol 2012; 188: 2537-2544.
21. Marsh MN and Crowe PT. Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin Gastroenterol 1995; 9: 273-293.
22. Oberhuber G, Granditsch G and Vogelsang H. The histopathology of coeliac disease: Time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11: 1185-1194.
23. Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322-1328.
24. Olaussen RW, Karlsson MR, Lundin KE, et al. Reduced chemokine receptor 9 on intraepithelial lymphocytes in celiac disease suggests persistent epithelial activation. Gastroenterology 2007; 132: 2371-2382.
25. Di Niro R, Mesin L, Zheng NY, et al. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med 2012; 18: 441-445.
26. Pepper M, Linehan JL, Pagan AJ, et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol 2010; 11: 83-89.
27. Meresse B, Chen Z, Ciszewski C, et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004; 21: 357-366.
28. Pais WP, Duerksen DR, Pettigrew NM, et al. How many duodenal biopsy specimens are required to make a diagnosis of celiac disease? Gastrointest Endosc 2008; 67: 1082-1087.
29. Jabri B and Sollid LM. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol 2009; 9: 858-870.
30. Qiao SW, Christophersen A, Lundin KE, et al. Biased usage and preferred pairing of alpha-and beta-chains of TCRs specific for an immunodominant gluten epitope in coeliac disease. Int Immunol 2014; 26: 13-19.
31. Knabel M, Franz TJ, Schiemann M, et al. Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer. Nat Med 2002; 8: 631-637.
32. Geiger R, Duhen T, Lanzavecchia A, et al. Human naive and memory CD4þ T-cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J Exp Med 2009; 206: 1525-1534.
33. Qiao SW, Raki M, Gunnarsen KS, et al. Post-translational modification of gluten shapes TCR usage in celiac disease. J Immunol 2011; 187: 3064-3071.
34. Kaukinen K, Maki M, Partanen J, et al. Celiac disease without villous atrophy: Revision of criteria called for. Dig Dis Sci 2001; 46: 879-887.
35. Rubio-Tapia A, Ludvigsson JF, Brantner TL, et al. The prevalence of celiac disease in the United States. Am J Gastroenterol 2012; 107: 1538-1544.